Overactive Bladder - Results from #90

REVIEW UroToday

Efficacy and safety of solifenacin combined with biofeedback in children with overactive bladder. April 28, 2024

The AUA/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder. April 25, 2024

Examining the safety of mirabegron: an analysis of real-world pharmacovigilance data from the US FDA adverse event reporting system (FAERS) database. April 23, 2024

Percutaneous tibial nerve stimulation for the overactive bladder: A single-arm trial. April 21, 2024

Percutaneous tibial neuromodulation initial therapy compliance and subsequent third-line treatment patterns. April 21, 2024

Association between overactive bladder and depression in American adults: A cross-sectional study from NHANES 2005-2018. April 21, 2024

Sacral neuromodulation in nursing home residents: Predictors of success and complications in a national cohort of older adults. April 21, 2024

Association of socioeconomic status and overactive bladder in US adults: a cross-sectional analysis of nationally representative data. April 14, 2024

Efficacy and Safety of Low-Dose Intravesical OnabotulinumtoxinA Injections in Female Patients With Detrusor Overactivity With Detrusor Underactivity. April 14, 2024

Fragility of overactive bladder medication clinical trials: A systematic review. April 14, 2024

The correlation between academic stress, overactive bladder syndrome (OAB) and quality of life among healthy university students: A cross-sectional study. April 3, 2024

Risks of Dementia After Treatment with an Anticholinergic, Beta-3 Agonist, or Combination of Both for an Overactive Bladder: A Korean National Cohort Study. April 3, 2024

Resolution of Overactive Bladder Symptoms After Anterior and Apical Prolapse Repair. March 31, 2024

Sacral Neuromodulation: Device Improvement and Current Applications in Urology. March 31, 2024

Predictors of non-persistence in women with overactive bladder syndrome. March 31, 2024

Title: Associations between Urinary Concentrations of Polycyclic Aromatic Hydrocarbons (PAHs) and Overactive Bladder (OAB) in United States Adults: Data from the National Health and Nutrition Examination Survey (NHANES) 2005-2016. March 31, 2024

CamiCon study: Evaluation of a new tool for automated and connected voiding calendar. March 31, 2024

Urodynamic insights: exploring the relationship between detrusor overactivity and pelvic organ prolapse in women with urge incontinence. March 31, 2024

Pathophysiology of Overactive Bladder and Pharmacologic Treatments Including β3-Adrenoceptor Agonists -Basic Research Perspectives. March 24, 2024

Efficacy and safety of tibial nerve stimulation using a wearable device for overactive bladder. March 24, 2024

Page 5 of 121